Table 2.
OS in entire cohort |
||||
---|---|---|---|---|
Univariate |
Multivariate* |
|||
HR (95% CI) | P | HR (95% CI) | P | |
CNR (<5 vs >5) | 0.1 (0.01–0.73) | 0.023 | 0.09 (0.01–0.76) | 0.027 |
Nodal status (positive vs negative) | 3.03 (1.48–6.20) | 0.002 | 2.71 (1.18–6.24) | 0.019 |
Grade (1 and 2 vs 3) | 2.52 (1.32–4.81) | 0.005 | 0.65 (0.27–1.55) | 0.330 |
ER status (positive vs negative) | 0.38 (0.20–0.73) | 0.004 | 0.58 (0.20–1.72) | 0.338 |
Her2 (1 and 2+ vs 3+) | 2.19 (1.06–4.52) | 0.034 | 2.04 (0.81–5.15) | 0.129 |
PR status (positive vs negative) | 0.41 (0.21–0.80) | 0.009 | 0.85 (0.35–2.07) | 0.727 |
Tumor size (continuous) | 1.04 (1.02–1.06) | 0.001 | 1.05 (1.02–1.08) | 0.002 |
Ki-67 (0–10% vs 11–100%) | 2.60 (1.01–6.67) | 0.047 | 0.98 (0.31–3.10) | 0.975 |
p53 (0–10% vs 11–100%) | 2.19 (1.15–4.17) | 0.017 | 0.93 (0.34–2.51) | 0.882 |
Adjusted for all other variables in the table.